ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,090.02
0.01%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Noticias

TEVA Teva Pharmaceutical Industries Ltd

16.31
0.01 (0.06%)
17 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Teva Pharmaceutical Industries Ltd TEVA NYSE Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.01 0.06% 16.31 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.14 16.05 16.35 16.29 16.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/5/202407:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202407:30EDGAR2Form 8-K - Current report
15/5/202407:15BWTeva Announces Appointment of Matthew Shields to Executive..
09/5/202406:53IHMARKETNEWSBain Capital in Talks to Acquire PowerSchool; Blackstone..
08/5/202406:00BWTeva Reports First Quarter 2024 Financial Results and..
08/5/202405:30BWTeva and Medincell Announce Positive Phase 3 Efficacy..
02/5/202417:30BWTeva to Present at the 2024 Bank of America Healthcare..
02/5/202407:30BWTeva’s 2023 Healthy Future Report Showcases Renewed..
30/4/202403:00BWU.S. Commercialization Agreement with Quallent to Drive..
16/4/202416:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202416:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/4/202407:00BWTeva’s New Real-World Evidence Presented at the 2024 AAN..
11/4/202407:30BWTeva Confirms Efficacy and Safety of AJOVY® (fremanezumab)..
09/4/202415:30BWTeva to Host Conference Call to Discuss First Quarter 2024..
06/4/202412:00BWNew Pharmacokinetic Modeling Data Presented by Teva..
04/4/202407:30BWTeva and mAbxience Announce Strategic Global Licensing..
01/4/202407:30BWClinical Collaboration Agreement between Teva and Launch..
07/3/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202405:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202406:00BWTeva and Jiangsu Nhwa Forge Strategic Partnership to Promote..
23/2/202419:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
23/2/202419:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
20/2/202407:30BWTeva Presents New Data Supporting Safety, Tolerability and..
13/2/202408:05IHMARKETNEWSHotter-Than-Expected Inflation Data Likely To Weigh On Wall..
12/2/202416:03IHMARKETNEWSDow Reaches New Record Closing High But Nasdaq, S&P 500 Give..
12/2/202408:13IHMARKETNEWSTeva Pharmaceutical, Urban Outfitters Upgraded
01/2/202406:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NYSE
TEVA
Teva Pharmaceutical Indu...
AMEX
NSU
Nevsun
ASX
ROGNA
Red Sky Energy
LSE
AJIA
Abrdn Japan Investment
EU
SOI
SOITEC
ASX
TGO
GrowthOps
LSE
0A3C
Medicrea
LSE
0O9L
M.w. Trade
LSE
0A22
Anheuser Busch Inbev Nv
LSE
0R6U
4sc
ASX
SMXN
Security Matters
NYSE
RGC
Regal Entertainment
ASX
SRK
Strike Resources
EU
ALSAS
Stradim Espac Fin
NASDAQ
ORPH
Orphazyme AS
EU
MLSMP
Semplicemente
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados